4//SEC Filing
Perry Nicole D 4
Accession 0001127602-21-021194
CIK 0001492422other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:01 PM ET
Size
8.1 KB
Accession
0001127602-21-021194
Insider Transaction Report
Form 4
Perry Nicole D
Vice President - Finance
Transactions
- Exercise/Conversion
Common Stock
2021-07-01$3.76/sh+1,000$3,760→ 5,847 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-07-01−1,000→ 7,161 totalExercise: $3.76Exp: 2025-07-31→ Common Stock (1,000 underlying) - Sale
Common Stock
2021-07-01$64.00/sh−1,000$64,000→ 4,847 total
Footnotes (2)
- [F1]This is a scheduled exercise from a 10B5-1 trading plan.
- [F2]This option was granted on July 31, 2015 and is fully vested.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001657874
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:01 PM ET
- Size
- 8.1 KB